Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Saw Palmetto and Improved Lower Urinary Tract Symptoms

Research synthesisLow evidenceMixed effect size3 studies · 2 beneficial · 1 neutral · 0 harmful

Across 3 studies, 2 reported beneficial effects (1 moderate, 1 small) and 1 was neutral, with 2 statistically significant findings. The predominant effect direction is beneficial, with a mixed effect size (moderate to small). The most-studied dose was 320 mg/day in a single 12-month RCT in treatment-naïve men with moderate-to-severe LUTS and prostate volume >30 cc. Effects were observed from Month 3 onward in that trial.

  • Effective dose range: 320 mg/day
  • Studied populations: treatment-naïve men with moderate-to-severe LUTS (IPSS > 7) and prostate volume > 30 cc

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. The highest-quality study combined saw palmetto with alfuzosin, so isolated effects of saw palmetto are not clear. The two review-level studies provide limited granularity on dose and form.

Generated May 13, 2026
Doses used in studies
  • mg/day: 320 (median 320, IQR 320320) 1 study
Time to effect
Median: 12.2 months · IQR 12.2 months12.2 months · Range 12.2 months12.2 months — Reported in 1 of 3 studies
Safety in these studies
3 of 3 papers
Back to top